Revelation Biosciences, Inc. (NASDAQ:REVBW) Sees Large Drop in Short Interest

Revelation Biosciences, Inc. (NASDAQ:REVBW) saw a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,300 shares, a drop of 23.5% from the March 31st total of 1,700 shares. Based on an average trading volume of 78,500 shares, the short-interest ratio is currently 0.0 days.

Revelation Biosciences Price Performance

Shares of NASDAQ:REVBW remained flat at $0.01 during trading on Tuesday. The stock had a trading volume of 4,632 shares, compared to its average volume of 73,298. Revelation Biosciences has a 1 year low of $0.01 and a 1 year high of $0.03. The business’s 50-day moving average price is $0.02 and its 200-day moving average price is $0.01.

Revelation Biosciences Company Profile

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.